These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 16274936

  • 1. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L, Shinohara ET, Kim D, Tan J, Osusky K, Shyr Y, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):263-71. PubMed ID: 16274936
    [Abstract] [Full Text] [Related]

  • 2. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE.
    Strahlenther Onkol; 2006 Jul 01; 182(7):400-7. PubMed ID: 16826359
    [Abstract] [Full Text] [Related]

  • 3. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

  • 4. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
    Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Buchdunger E, Black PM, Stiles CD.
    Cancer Res; 2000 Sep 15; 60(18):5143-50. PubMed ID: 11016641
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD, Kalebic T, Torrens M, Kalogera-Fountzila A, Karkavelas G, Karanastasi S, Fletcher JA, Fountzilas G.
    Clin Cancer Res; 2009 Oct 01; 15(19):6258-66. PubMed ID: 19789313
    [Abstract] [Full Text] [Related]

  • 6. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G, Timeus F, Rinaldi A, Crescenzio N, Spinelli M, Rosolen A, Ricotti E, Basso G.
    Int J Mol Med; 2004 Sep 01; 14(3):373-82. PubMed ID: 15289888
    [Abstract] [Full Text] [Related]

  • 7. [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T].
    Zhang PY, Li BJ, Su XD, Wen ZS, Zhao JM, Zhang LJ, Long H, Rong TH.
    Ai Zheng; 2006 Apr 01; 25(4):456-60. PubMed ID: 16613680
    [Abstract] [Full Text] [Related]

  • 8. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.
    Cancer Res; 2011 Dec 01; 71(23):7155-67. PubMed ID: 22006998
    [Abstract] [Full Text] [Related]

  • 9. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 11. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 12. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.
    Clin Cancer Res; 2007 Dec 01; 13(23):7155-65. PubMed ID: 18056196
    [Abstract] [Full Text] [Related]

  • 13. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ.
    Clin Cancer Res; 2005 May 01; 11(9):3475-84. PubMed ID: 15867250
    [Abstract] [Full Text] [Related]

  • 14. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D, Callahan R.
    Oncogene; 2007 Feb 01; 26(5):662-72. PubMed ID: 16878155
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):888-96. PubMed ID: 17293239
    [Abstract] [Full Text] [Related]

  • 16. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
    Mukherjee J, Kamnasaran D, Balasubramaniam A, Radovanovic I, Zadeh G, Kiehl TR, Guha A.
    Cancer Res; 2009 Jun 15; 69(12):5099-107. PubMed ID: 19509233
    [Abstract] [Full Text] [Related]

  • 17. Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice.
    Cardinale RM, Dillehay LE, Williams JA, Tabassi K, Brem H, Lee DJ.
    Radiat Oncol Investig; 1998 Jun 15; 6(2):63-70. PubMed ID: 9572682
    [Abstract] [Full Text] [Related]

  • 18. Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
    Holdhoff M, Kreuzer KA, Appelt C, Scholz R, Na IK, Hildebrandt B, Riess H, Jordan A, Schmidt CA, Van Etten RA, Dörken B, le Coutre P.
    Blood Cells Mol Dis; 2005 Jun 15; 34(2):181-5. PubMed ID: 15727903
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.
    Yoshitani K, Honoki K, Morishita T, Kido A, Miyauchi Y, Mii Y, Takakura Y.
    In Vivo; 2003 Jun 15; 17(3):255-8. PubMed ID: 12929576
    [Abstract] [Full Text] [Related]

  • 20. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro.
    Zhang P, Gao WY, Turner S, Ducatman BS.
    Mol Cancer; 2003 Jan 03; 2():1. PubMed ID: 12537587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.